CN110772664A - A kind of preparation method of surface intelligent coating of orthopaedic temporary implant based on natural polysaccharide and product thereof - Google Patents
A kind of preparation method of surface intelligent coating of orthopaedic temporary implant based on natural polysaccharide and product thereof Download PDFInfo
- Publication number
- CN110772664A CN110772664A CN201911162214.8A CN201911162214A CN110772664A CN 110772664 A CN110772664 A CN 110772664A CN 201911162214 A CN201911162214 A CN 201911162214A CN 110772664 A CN110772664 A CN 110772664A
- Authority
- CN
- China
- Prior art keywords
- polysaccharide
- orthopaedic
- solution
- temporary implant
- temporary
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 229920001282 polysaccharide Polymers 0.000 title claims abstract description 77
- 239000005017 polysaccharide Substances 0.000 title claims abstract description 77
- 150000004676 glycans Chemical class 0.000 title claims abstract description 76
- 239000007943 implant Substances 0.000 title claims abstract description 62
- 239000011248 coating agent Substances 0.000 title claims abstract description 28
- 238000000576 coating method Methods 0.000 title claims abstract description 28
- 238000002360 preparation method Methods 0.000 title claims abstract description 18
- 238000007037 hydroformylation reaction Methods 0.000 claims abstract description 40
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 37
- 239000002131 composite material Substances 0.000 claims abstract description 25
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 claims abstract description 24
- JQWHASGSAFIOCM-UHFFFAOYSA-M sodium periodate Chemical compound [Na+].[O-]I(=O)(=O)=O JQWHASGSAFIOCM-UHFFFAOYSA-M 0.000 claims abstract description 24
- 239000000463 material Substances 0.000 claims abstract description 23
- 230000003014 reinforcing effect Effects 0.000 claims abstract description 15
- 239000007788 liquid Substances 0.000 claims abstract description 13
- 238000002156 mixing Methods 0.000 claims abstract description 12
- 229910000029 sodium carbonate Inorganic materials 0.000 claims abstract description 12
- 239000003431 cross linking reagent Substances 0.000 claims abstract description 9
- 230000000399 orthopedic effect Effects 0.000 claims abstract description 7
- 230000003115 biocidal effect Effects 0.000 claims abstract description 5
- 238000000034 method Methods 0.000 claims description 29
- 239000003242 anti bacterial agent Substances 0.000 claims description 20
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 claims description 19
- 239000000661 sodium alginate Substances 0.000 claims description 19
- 235000010413 sodium alginate Nutrition 0.000 claims description 19
- 229940005550 sodium alginate Drugs 0.000 claims description 19
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 claims description 16
- 229940088710 antibiotic agent Drugs 0.000 claims description 16
- 108010010803 Gelatin Proteins 0.000 claims description 12
- 229920000159 gelatin Polymers 0.000 claims description 12
- 239000008273 gelatin Substances 0.000 claims description 12
- 235000019322 gelatine Nutrition 0.000 claims description 12
- 235000011852 gelatine desserts Nutrition 0.000 claims description 12
- 239000012528 membrane Substances 0.000 claims description 12
- 238000006243 chemical reaction Methods 0.000 claims description 8
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 claims description 6
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 claims description 5
- 229920002307 Dextran Polymers 0.000 claims description 4
- 229920002385 Sodium hyaluronate Polymers 0.000 claims description 4
- 229940010747 sodium hyaluronate Drugs 0.000 claims description 4
- 229920001277 pectin Polymers 0.000 claims description 3
- 239000001814 pectin Substances 0.000 claims description 3
- 235000010987 pectin Nutrition 0.000 claims description 3
- 229920001285 xanthan gum Polymers 0.000 claims description 3
- 241000220479 Acacia Species 0.000 claims description 2
- 229920000936 Agarose Polymers 0.000 claims description 2
- AZKVWQKMDGGDSV-BCMRRPTOSA-N Genipin Chemical compound COC(=O)C1=CO[C@@H](O)[C@@H]2C(CO)=CC[C@H]12 AZKVWQKMDGGDSV-BCMRRPTOSA-N 0.000 claims description 2
- 235000010643 Leucaena leucocephala Nutrition 0.000 claims description 2
- 229920001218 Pullulan Polymers 0.000 claims description 2
- 239000004373 Pullulan Substances 0.000 claims description 2
- 229920002472 Starch Polymers 0.000 claims description 2
- 239000001913 cellulose Substances 0.000 claims description 2
- 229920002678 cellulose Polymers 0.000 claims description 2
- 235000010980 cellulose Nutrition 0.000 claims description 2
- 229960002086 dextran Drugs 0.000 claims description 2
- AZKVWQKMDGGDSV-UHFFFAOYSA-N genipin Natural products COC(=O)C1=COC(O)C2C(CO)=CCC12 AZKVWQKMDGGDSV-UHFFFAOYSA-N 0.000 claims description 2
- FZWBNHMXJMCXLU-BLAUPYHCSA-N isomaltotriose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@H](OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O)O1 FZWBNHMXJMCXLU-BLAUPYHCSA-N 0.000 claims description 2
- 235000019423 pullulan Nutrition 0.000 claims description 2
- 230000035484 reaction time Effects 0.000 claims description 2
- 238000002791 soaking Methods 0.000 claims description 2
- 239000008107 starch Substances 0.000 claims description 2
- 235000019698 starch Nutrition 0.000 claims description 2
- 229940032147 starch Drugs 0.000 claims description 2
- 239000000230 xanthan gum Substances 0.000 claims description 2
- 235000010493 xanthan gum Nutrition 0.000 claims description 2
- 229940082509 xanthan gum Drugs 0.000 claims description 2
- 229920001543 Laminarin Polymers 0.000 claims 1
- 239000011247 coating layer Substances 0.000 claims 1
- 238000001035 drying Methods 0.000 claims 1
- DBTMGCOVALSLOR-VPNXCSTESA-N laminarin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)OC1O[C@@H]1[C@@H](O)C(O[C@H]2[C@@H]([C@@H](CO)OC(O)[C@@H]2O)O)O[C@H](CO)[C@H]1O DBTMGCOVALSLOR-VPNXCSTESA-N 0.000 claims 1
- 238000005406 washing Methods 0.000 claims 1
- 230000000844 anti-bacterial effect Effects 0.000 abstract description 22
- 230000000694 effects Effects 0.000 description 8
- 241000894006 Bacteria Species 0.000 description 7
- 239000008367 deionised water Substances 0.000 description 7
- 229910021641 deionized water Inorganic materials 0.000 description 7
- 239000000203 mixture Substances 0.000 description 7
- 230000001954 sterilising effect Effects 0.000 description 7
- 238000004659 sterilization and disinfection Methods 0.000 description 7
- 230000001580 bacterial effect Effects 0.000 description 6
- 230000000052 comparative effect Effects 0.000 description 6
- 230000007774 longterm Effects 0.000 description 6
- 229920001661 Chitosan Polymers 0.000 description 5
- 230000010261 cell growth Effects 0.000 description 5
- 239000003153 chemical reaction reagent Substances 0.000 description 5
- 239000003102 growth factor Substances 0.000 description 5
- 229910001069 Ti alloy Inorganic materials 0.000 description 4
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 239000010936 titanium Substances 0.000 description 4
- 229910052719 titanium Inorganic materials 0.000 description 4
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 3
- 238000010586 diagram Methods 0.000 description 3
- 229910021389 graphene Inorganic materials 0.000 description 3
- 208000015181 infectious disease Diseases 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- MWUXSHHQAYIFBG-UHFFFAOYSA-N nitrogen oxide Inorganic materials O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 description 3
- 206010059866 Drug resistance Diseases 0.000 description 2
- 241000588724 Escherichia coli Species 0.000 description 2
- 229920001046 Nanocellulose Polymers 0.000 description 2
- 206010034133 Pathogen resistance Diseases 0.000 description 2
- 239000004372 Polyvinyl alcohol Substances 0.000 description 2
- 239000002262 Schiff base Substances 0.000 description 2
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 2
- 125000003172 aldehyde group Chemical group 0.000 description 2
- 125000003277 amino group Chemical group 0.000 description 2
- 230000002924 anti-infective effect Effects 0.000 description 2
- 239000002585 base Substances 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 238000005266 casting Methods 0.000 description 2
- 238000007654 immersion Methods 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 239000002105 nanoparticle Substances 0.000 description 2
- 238000011056 performance test Methods 0.000 description 2
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 2
- 229920002451 polyvinyl alcohol Polymers 0.000 description 2
- 150000003856 quaternary ammonium compounds Chemical class 0.000 description 2
- 238000001338 self-assembly Methods 0.000 description 2
- 229910052709 silver Inorganic materials 0.000 description 2
- 239000004332 silver Substances 0.000 description 2
- 238000006557 surface reaction Methods 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- GJCOSYZMQJWQCA-UHFFFAOYSA-N 9H-xanthene Chemical compound C1=CC=C2CC3=CC=CC=C3OC2=C1 GJCOSYZMQJWQCA-UHFFFAOYSA-N 0.000 description 1
- 208000031729 Bacteremia Diseases 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 206010064687 Device related infection Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 229920002873 Polyethylenimine Chemical class 0.000 description 1
- FOIXSVOLVBLSDH-UHFFFAOYSA-N Silver ion Chemical compound [Ag+] FOIXSVOLVBLSDH-UHFFFAOYSA-N 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 206010066901 Treatment failure Diseases 0.000 description 1
- 238000002679 ablation Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 230000003044 adaptive effect Effects 0.000 description 1
- -1 aldehydes Polysaccharide Chemical class 0.000 description 1
- 230000003373 anti-fouling effect Effects 0.000 description 1
- 239000003899 bactericide agent Substances 0.000 description 1
- 239000003139 biocide Substances 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 125000002091 cationic group Chemical group 0.000 description 1
- 229920006317 cationic polymer Polymers 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 230000009089 cytolysis Effects 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000004945 emulsification Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 238000010335 hydrothermal treatment Methods 0.000 description 1
- 238000002513 implantation Methods 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 239000012567 medical material Substances 0.000 description 1
- 230000007721 medicinal effect Effects 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 239000003504 photosensitizing agent Substances 0.000 description 1
- 239000012221 photothermal agent Substances 0.000 description 1
- 238000007745 plasma electrolytic oxidation reaction Methods 0.000 description 1
- 229910052697 platinum Inorganic materials 0.000 description 1
- 229920001606 poly(lactic acid-co-glycolic acid) Polymers 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000002787 reinforcement Effects 0.000 description 1
- 239000012744 reinforcing agent Substances 0.000 description 1
- 238000004088 simulation Methods 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 238000007910 systemic administration Methods 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/28—Materials for coating prostheses
- A61L27/34—Macromolecular materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/54—Biologically active materials, e.g. therapeutic substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
- A61L2300/406—Antibiotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
- A61L2300/606—Coatings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2430/00—Materials or treatment for tissue regeneration
- A61L2430/02—Materials or treatment for tissue regeneration for reconstruction of bones; weight-bearing implants
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Dermatology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Transplantation (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Materials For Medical Uses (AREA)
Abstract
本发明公开了一种基于天然多糖的骨科临时植入体的表面智能涂层的制备方法,步骤为:1)将第一种多糖和高碘酸钠反应,得到醛化度为55%~65%的醛化多糖;2)将补强多糖在热水中溶解,得到溶液a,将抗生素溶于pH=9~10的碳酸钠溶液,得到溶液b,将溶液b加入溶液a中混合均匀,加入步骤1)所述的醛化多糖,制得成膜液;3)在反应器中放入骨科临时植入体,加入步骤2)所述的成膜液,在30~60℃缓慢挥发,将骨科临时植入体表面均匀包裹上复合膜;4)将步骤3)中制得的材料放入加入交联剂溶液中浸泡5~20min,取出用水清洗,烘干,得到修饰上复合膜的骨科临时植入体。本发明产品抗菌效果优异。
The invention discloses a preparation method of a natural polysaccharide-based orthopaedic temporary implant surface intelligent coating. The steps are: 1) reacting a first polysaccharide with sodium periodate to obtain a degree of hydroformylation of 55% to 65%. 2) Dissolving the reinforcing polysaccharide in hot water to obtain solution a, dissolving the antibiotic in a sodium carbonate solution with pH=9 to 10 to obtain solution b, adding solution b to solution a and mixing evenly, Add the hydroformyl polysaccharide described in step 1) to prepare a film-forming liquid; 3) put a temporary orthopaedic implant in the reactor, add the film-forming liquid described in step 2), and slowly volatilize at 30-60 °C, The surface of the orthopaedic temporary implant is evenly wrapped with a composite film; 4) the material prepared in step 3) is put into a solution of adding a cross-linking agent, soaked for 5-20 minutes, taken out, washed with water, and dried to obtain a composite film modified with a composite film. Orthopedic temporary implants. The product of the invention has excellent antibacterial effect.
Description
技术领域technical field
本发明属于医用材料领域,涉及一种基于天然多糖的骨科临时植入体的表面智能涂层的制备方法及其产品。The invention belongs to the field of medical materials, and relates to a preparation method and a product of a surface intelligent coating of a natural polysaccharide-based orthopaedic temporary implant.
背景技术Background technique
骨科临床上经常发生植入物相关感染,主要为细菌局部繁殖、菌血症这两大问题。骨科植入体感染存在高发性、反复性和迟发性的特点,往往导致治疗失败,甚至危及患者的健康。为了解决骨科植入体的感染问题,在表面功能化方面已经做了许多的努力。例如,在表面构建阳离子涂层进行接触式杀菌。在文献报道的杀菌阳离子聚合物中,季铵盐化合物(QACs)衍生的聚阳离子,聚乙烯亚胺衍生物,壳聚糖衍生物等通过膜裂解机制破坏细菌细胞膜的完整性,使细胞内容物泄出而显示强大的抗菌活性。此外,也可在表面负载杀菌剂,进行释放型杀菌。生物杀灭剂包括银纳米粒子(AgNPs)、抗生素和氮氧化物等被预先加载或嵌入,然后缓慢释放到附近环境中以杀灭细菌。还有报道在表面修饰光敏剂进行光热杀菌,利用近红外光照射光热剂材料铂、金等产生过高热,通过热消融方式杀死细菌。Implant-related infections often occur clinically in orthopaedics, mainly due to the two major problems of local bacterial proliferation and bacteremia. Orthopedic implant infection has the characteristics of high incidence, recurrence and delay, which often lead to treatment failure and even endanger the health of patients. To address the infection problem of orthopaedic implants, many efforts have been made in surface functionalization. For example, build a cationic coating on the surface for contact sterilization. Among the bactericidal cationic polymers reported in the literature, polycations derived from quaternary ammonium compounds (QACs), polyethyleneimine derivatives, chitosan derivatives, etc. disrupt the integrity of bacterial cell membranes through membrane lysis mechanisms, allowing cell contents Leak and show strong antibacterial activity. In addition, a bactericide can be loaded on the surface for release-type sterilization. Biocides including silver nanoparticles (AgNPs), antibiotics, and nitrogen oxides are preloaded or embedded and then slowly released into the nearby environment to kill bacteria. It is also reported that photothermal sterilization is carried out on the surface modified photosensitizer, and the photothermal agent materials such as platinum and gold are irradiated with near-infrared light to generate excessive heat, and bacteria are killed by thermal ablation.
中国专利公开号CN106512083A公开了一种医用钛合金的制备方法。该专利运用双乳液法、水热法处理等使PLGA载药纳米粒子接到钛基表面,所制备的产品具有良好的生物活性和抗菌性能。但该方法步骤繁琐,实验过程中涉及强酸强碱,存在一定危险性,缺乏高效实用性。Chinese Patent Publication No. CN106512083A discloses a preparation method of medical titanium alloy. The patent uses double emulsion method, hydrothermal treatment, etc. to make PLGA drug-loaded nanoparticles connect to the surface of titanium base, and the prepared product has good biological activity and antibacterial properties. However, this method has complicated steps and involves strong acid and strong base in the experimental process, which is dangerous and lacks high efficiency and practicability.
中国专利公开号CN102758202B公开了一种医用钛及钛合金表面抗菌涂层的制备方法。该专利通过将纳米预涂层制备、载银处理与微弧氧化技术相结合,实现了银在医用钛及钛合金表面的大量固定和长期缓慢释放,能够显著提高钛及钛合金的抗菌性能,并使抗菌效果能够长时间维持。但该方法中的抗菌剂银存在一定的生物毒性,使得该方法的应用受到一定的限制。Chinese Patent Publication No. CN102758202B discloses a preparation method of an antibacterial coating on the surface of medical titanium and titanium alloys. This patent combines the preparation of nano-precoating, silver-loading treatment and micro-arc oxidation technology to achieve a large amount of silver fixation and long-term slow release on the surface of medical titanium and titanium alloys, which can significantly improve the antibacterial properties of titanium and titanium alloys. And the antibacterial effect can be maintained for a long time. However, the antibacterial agent silver in this method has certain biological toxicity, which limits the application of this method.
中国专利公开号CN106867042A公开了一种流延法制备纳米纤维素/壳聚糖/聚乙烯醇复合膜及其在生物抗菌膜中的应用方法。该专利以聚乙烯醇为基体聚合物,纳米纤维素为增强剂、壳聚糖为天然抗菌剂采用流延法完成复合膜产品制备工艺。该方法制备的复合膜易操作、力学性能优异、光学性能良好,但壳聚糖的牢固结合,长期存在容易导致细菌的耐药性。Chinese Patent Publication No. CN106867042A discloses a method for preparing nanocellulose/chitosan/polyvinyl alcohol composite film by casting method and its application method in biological antibacterial film. The patent uses polyvinyl alcohol as the matrix polymer, nanocellulose as the reinforcing agent, and chitosan as the natural antibacterial agent to complete the preparation process of the composite film product by the casting method. The composite membrane prepared by this method is easy to operate, has excellent mechanical properties and good optical properties, but the firm combination of chitosan can easily lead to bacterial drug resistance due to the long-term existence of chitosan.
中国专利公开号CN103191467A公开了一种医用金属表面缓释多种细胞生长因子的抗菌涂层的制备方法。该方法采用酰胺键共价结合的方式在氧化石墨烯上接枝带氨基的抗生素,并通过层层自组装的方法将分别包裹多种细胞生长因子的纳米颗粒固定在氧化石墨烯层之间,从而在医用金属表面得到同时载有多种细胞生长因子及抗生素的涂层。该法制备的涂层能够独立控制各种细胞生长因子的缓慢有序释放,并且能在细胞生长因子缓慢释放的整个过程中,均有抗生素的释放。但该方法无法调控抗生素的自适应释放,采用的氧化石墨烯具有潜在的毒性,同时层层自组装缺乏一定的高效实用性。Chinese Patent Publication No. CN103191467A discloses a preparation method of an antibacterial coating for slow-release of various cell growth factors on a medical metal surface. In this method, the antibiotics with amino groups are grafted on graphene oxide by covalent bonding of amide bonds, and the nanoparticles wrapped with various cell growth factors are fixed between the graphene oxide layers by layer-by-layer self-assembly method. As a result, a coating simultaneously loaded with a variety of cell growth factors and antibiotics is obtained on the medical metal surface. The coating prepared by the method can independently control the slow and orderly release of various cell growth factors, and can release antibiotics in the whole process of the slow release of cell growth factors. However, this method cannot control the adaptive release of antibiotics, the graphene oxide used is potentially toxic, and the layer-by-layer self-assembly lacks a certain high efficiency and practicality.
如上所述,表面功能化仍存在一定的问题,抗菌剂长期存在诱发细菌耐药性,细菌易在表面定植导致抗菌剂失效,植入体表面相容性差,所选材料具有一定毒性等。为解决以上问题,本发明希望开发一种制备工艺简单,具有良好生物相容性和自适应释放抗菌性能的智能涂层。智能涂层是指通过对骨科临时植入体进行表面修饰,使其具有细菌应答能力,能够通过自适应释放抗菌物质进行杀菌,以达到抗感染的目的,从而提高植入手术的成功率。本发明开发的智能涂层通过在表面牢固天然多糖提供反应位点,使植入体具有良好的生物相容性。抗生素与多糖位点通过对细菌酸性微环境具有响应断裂性的席夫碱键连接,使抗生素能够自适应性释放杀菌,从而实现细菌的快速精准高效杀灭,同时极大程度的避免了细菌耐药性的产生。As mentioned above, there are still some problems in surface functionalization. Antibacterial agents have long-term induced bacterial resistance, bacteria are easily colonized on the surface, leading to the failure of antibacterial agents, poor compatibility of implant surfaces, and certain toxicity of selected materials. In order to solve the above problems, the present invention hopes to develop an intelligent coating with simple preparation process, good biocompatibility and self-adaptive release antibacterial properties. Smart coating refers to the surface modification of orthopaedic temporary implants to make them responsive to bacteria and sterilize by adaptively releasing antibacterial substances to achieve the purpose of anti-infection, thereby improving the success rate of implantation operations. The smart coating developed by the present invention provides the reaction site with firm natural polysaccharide on the surface, so that the implant has good biocompatibility. Antibiotics and polysaccharide sites are connected by Schiff base bonds that respond to the acidic microenvironment of bacteria, so that antibiotics can be adaptively released for sterilization, so as to achieve rapid, accurate and efficient killing of bacteria, while avoiding bacterial resistance to a great extent. production of medicinal properties.
发明内容SUMMARY OF THE INVENTION
有鉴于此,本发明的目的在于既能使植入体具有良好的生物相容性,又具备优异的抗感染性能,提供一种基于天然多糖的骨科临时植入体的表面智能涂层的制备方法。In view of this, the purpose of the present invention is to not only make the implant have good biocompatibility, but also have excellent anti-infection performance, and provide a kind of preparation of the surface intelligent coating of the orthopaedic temporary implant based on natural polysaccharide method.
本发明具体提供了如下的技术方案:The present invention specifically provides the following technical solutions:
1、一种基于天然多糖的骨科临时植入体的表面智能涂层的制备方法,步骤为:1, a kind of preparation method of the surface intelligent coating of the orthopaedic temporary implant based on natural polysaccharide, the steps are:
1)将第一种多糖和高碘酸钠反应,得到醛化度为55%~65%的醛化多糖;1) reacting the first polysaccharide with sodium periodate to obtain an hydroformylation polysaccharide with a degree of hydroformylation of 55% to 65%;
2)将补强多糖在热水中溶解,得到溶液a,将抗生素溶于pH=9~10的碳酸钠溶液,得到溶液b,将溶液b加入溶液a中混合均匀,加入步骤1)所述的醛化多糖,制得成膜液;2) Dissolving the reinforcing polysaccharide in hot water to obtain solution a, dissolving the antibiotic in a sodium carbonate solution with pH=9~10 to obtain solution b, adding solution b to solution a and mixing evenly, adding the step 1) described The hydroformylation polysaccharide was obtained to obtain a film-forming liquid;
3)在反应器中放入骨科临时植入体,加入步骤2)所述的成膜液,在30~60℃缓慢挥发,将骨科临时植入体表面均匀包裹上复合膜;3) Putting the temporary orthopaedic implant into the reactor, adding the film-forming liquid described in step 2), and slowly volatilizing at 30-60°C, and evenly wrapping the surface of the temporary orthopaedic implant with a composite film;
4)将步骤3)中制得的材料放入加入交联剂溶液中浸泡5~20min,取出用水清洗,烘干,得到修饰上复合膜的骨科临时植入体。4) Put the material prepared in step 3) into the solution with added cross-linking agent, soak for 5-20 minutes, take out, wash with water, and dry to obtain a temporary orthopaedic implant modified with a composite membrane.
进一步,步骤1)所述的第一种多糖为纤维素、淀粉、海藻酸钠、透明质酸钠、葡聚糖、普鲁兰多糖、琼脂糖或昆布糖,步骤2)所述的补强多糖为明胶、黄原胶、果胶或阿拉伯树胶。Further, the first polysaccharide described in step 1) is cellulose, starch, sodium alginate, sodium hyaluronate, dextran, pullulan, agarose or laminose, and the reinforcing described in step 2) The polysaccharide is gelatin, xanthan, pectin or acacia.
进一步,步骤1)所述的第一种多糖为海藻酸钠,步骤2)所述的补强多糖为明胶。Further, the first polysaccharide described in step 1) is sodium alginate, and the reinforcing polysaccharide described in step 2) is gelatin.
进一步,按质量份数计,步骤1)所述的第一种多糖为1~15份,高碘酸钠为0.1~5份,步骤2)所述的醛化多糖为1~10份,补强多糖为5~50份,碳酸钠为0.5~5份,抗生素为0.1~3份,步骤3)所述的交联剂为1~3份,其中,补强多糖的份数应高于醛化多糖份数。Further, in terms of parts by mass, the first polysaccharide described in step 1) is 1-15 parts, the sodium periodate is 0.1-5 parts, the hydroformyl polysaccharide described in step 2) is 1-10 parts, and the supplement 5-50 parts of strong polysaccharides, 0.5-5 parts of sodium carbonate, 0.1-3 parts of antibiotics, and 1-3 parts of the cross-linking agent described in step 3), wherein the parts of reinforcing polysaccharides should be higher than that of aldehydes Polysaccharide fractions.
进一步,步骤2)所述的醛化多糖为1~5份,补强多糖2~10份。Further, the hydroformylation polysaccharide described in step 2) is 1-5 parts, and the reinforcing polysaccharide is 2-10 parts.
进一步,步骤1)所述的反应的反应温度为25℃~37℃,反应时间为20h~30h。Further, the reaction temperature of the reaction in step 1) is 25°C to 37°C, and the reaction time is 20h to 30h.
进一步,步骤2)所述的热水的温度为60~100℃。Further, the temperature of the hot water in step 2) is 60-100°C.
进一步,步骤3)所述的挥发的时间为7h~10h。Further, the volatilization time in step 3) is 7h-10h.
进一步,步骤4)所述的交联剂为京尼平、戊二醛或甲醛。Further, the cross-linking agent described in step 4) is genipin, glutaraldehyde or formaldehyde.
2、根据上述一种基于天然多糖的骨科临时植入体的表面智能涂层的制备方法制备得到的材料。2. A material prepared according to the above-mentioned preparation method for a surface intelligent coating of a natural polysaccharide-based orthopaedic temporary implant.
本发明的有益效果在于:The beneficial effects of the present invention are:
(1)本发明通过两种不同多糖,一种为补强多糖,另一种为醛化多糖,在30~60℃共混缓慢挥发,使分子链由无规状态逐渐变得有序规整,通过氢键作用等在材料表面形成网络体系,通过一步法在表面实现肉眼可见的涂层修饰,制备方法操作简单,实验过程绿色环保,结果可控,制备成本低。本发明在调控多糖配比时选用补强多糖比例高于醛化多糖是因为当醛化多糖比例过高时会导致两种多糖之间的交联程度增加,分子链缠结更紧密,分子链移动速度变慢,水分挥发时分子链来不及重排导致表面膜破裂,而明胶仍保持蛋白质弹性的特性,当其配比高时分子链具有一定的弹性,水分挥发时分子链间距随之缩短,表面均匀成膜。(1) The present invention uses two different polysaccharides, one is a reinforcing polysaccharide and the other is an hydroformylation polysaccharide, which is slowly volatilized by blending at 30-60 ° C, so that the molecular chain gradually becomes orderly and regular from a random state, A network system is formed on the surface of the material through hydrogen bonding, etc., and a coating modification visible to the naked eye is realized on the surface through a one-step method. The preparation method is simple to operate, the experimental process is green and environmentally friendly, the results are controllable, and the preparation cost is low. In the present invention, the ratio of reinforcing polysaccharide is higher than that of hydroformylation polysaccharide when regulating the proportion of polysaccharide, because when the ratio of hydroformylation polysaccharide is too high, the degree of cross-linking between the two polysaccharides will increase, the molecular chain will be more tightly entangled, and the molecular chain will be more tightly entangled. The moving speed slows down, and the molecular chain does not have time to rearrange when the water volatilizes, resulting in the rupture of the surface film, while the gelatin still maintains the characteristics of protein elasticity. When the proportion of the molecular chain is high, the molecular chain has a certain elasticity. The surface is uniformly formed into a film.
(2)本发明采用共混挥发时醛化多糖上的醛基与抗生素的氨基形成的席夫碱键实现抗生素的自适应释放,较全身给药方式可在局部形成较高浓度而不进入循环系统,对身体重要脏器无毒副作用,实现智能化快速高效精准杀菌,并有效减少细菌耐药性的产生。(2) The present invention adopts the Schiff base bond formed by the aldehyde group on the hydroformylation polysaccharide and the amino group of the antibiotic during blending and volatilization to realize the self-adaptive release of the antibiotic. Compared with the systemic administration method, a higher concentration can be locally formed without entering the circulation. The system has no toxic and side effects on important organs of the body, realizes intelligent, fast, efficient and accurate sterilization, and effectively reduces the generation of bacterial drug resistance.
(3)本发明交联剂的使用使该材料在利用明胶良好补强成膜效果的同时规避其结构易解散的问题,使表面涂层能实现长效稳定抗菌效果。由于明胶是温敏材料,在人体37℃环境中其结构会发生解散,体外模拟实验表明表面涂层在37℃生理盐水中浸泡1~6h可完全溶解,不符合长期稳定设想,通过步骤4)的交联剂对膜进行后处理可以使其具有良好的稳定性,体外模拟7天37℃浸泡实验,经过7天的浸泡表面涂层未发生结构解散现象,将该浸泡材料进行抗菌实验仍具有良好的抗菌效果。(3) The use of the cross-linking agent of the present invention enables the material to use gelatin to enhance the film-forming effect while avoiding the problem that its structure is easily disintegrated, so that the surface coating can achieve a long-term stable antibacterial effect. Since gelatin is a temperature-sensitive material, its structure will dissolve in the human body at 37°C. In vitro simulation experiments show that the surface coating can be completely dissolved by soaking in normal saline at 37°C for 1 to 6 hours, which does not meet the long-term stability assumption. Step 4) The post-treatment of the film with the cross-linking agent can make it have good stability. After 7 days of immersion experiment at 37 °C in vitro, no structural dissolution of the surface coating occurred after 7 days of immersion. Good antibacterial effect.
(4)本发明采用来源广泛的天然多糖提供反应位点,使得修饰的植入体生物相容性好,具有良好抗污效果,安全无毒,可直接用于医疗用途。(4) The present invention uses natural polysaccharides from a wide range to provide reaction sites, so that the modified implant has good biocompatibility, good antifouling effect, is safe and non-toxic, and can be directly used for medical purposes.
(5)本发明抗菌性能优异,具有长期稳定的抗菌效果,可从一定程度上减少骨科手术中的感染。(5) The invention has excellent antibacterial performance, has long-term stable antibacterial effect, and can reduce infection in orthopedic surgery to a certain extent.
附图说明Description of drawings
为了使本发明的目的、技术方案和有益效果更加清楚,本发明提供如下附图:In order to make the purpose, technical solutions and beneficial effects of the present invention clearer, the present invention provides the following accompanying drawings:
图1为按照实施例1的植入体材料表面修饰前后效果对比图。FIG. 1 is a comparison diagram of the effect before and after the surface modification of the implant material according to Example 1. FIG.
图2为按照实施例1的步骤(1)将多糖进行醛化前后对比及希夫试剂表征。Fig. 2 shows the comparison before and after hydroformylation of polysaccharide according to step (1) of Example 1 and the characterization of Schiff's reagent.
图3为按照实施例2、4、5得到的基于天然多糖的骨科临时植入体的表面智能涂层的抗菌效果图。3 is a graph showing the antibacterial effect of the smart coating on the surface of the natural polysaccharide-based orthopaedic temporary implant obtained according to Examples 2, 4, and 5.
图4为对比例1和对比例2的植入体表面成膜效果图。FIG. 4 is a graph showing the effect of film formation on the implant surface of Comparative Example 1 and Comparative Example 2. FIG.
具体实施方式Detailed ways
下面结合附图,对本发明的优选实施例进行详细的描述。The preferred embodiments of the present invention will be described in detail below with reference to the accompanying drawings.
实施例1Example 1
(1)将1g海藻酸钠用0.432g高碘酸钠在25℃下反应24h,然后用去离子水透析3天,冻干,得到所需的醛化度为35%的醛化海藻酸钠;(1) 1 g of sodium alginate was reacted with 0.432 g of sodium periodate at 25°C for 24 hours, then dialyzed with deionized water for 3 days, and freeze-dried to obtain the required hydroformylation sodium alginate with a degree of hydroformylation of 35%. ;
(2)在西林瓶中加入150mg明胶,加入3mL水在60℃加热溶解,得到溶液1,称取20mg抗生素溶于2mL pH=10的碳酸钠溶液,得到溶液2,将溶液2加入溶液1中混合均匀,混合一段时间后加入50mg的醛化度为35%的醛化海藻酸钠,制得成膜液;(2) Add 150 mg of gelatin to the vial, add 3 mL of water and heat to dissolve at 60°C to obtain solution 1, weigh 20 mg of antibiotics and dissolve in 2 mL of pH=10 sodium carbonate solution to obtain solution 2, add solution 2 to solution 1 Mix evenly, and after mixing for a period of time, add 50 mg of hydroformyl sodium alginate with a degree of hydroformylation of 35% to prepare a film-forming liquid;
(3)在反应器中放入骨科临时植入体,加入成膜液,整个体系在40℃缓慢挥发7h,骨科临时植入体表面均匀包裹上复合膜。(3) Put the orthopaedic temporary implant in the reactor, add the film-forming solution, the whole system is slowly volatilized at 40°C for 7 hours, and the surface of the orthopaedic temporary implant is evenly wrapped with a composite film.
(4)用水配制质量分数为2.5%的戊二醛溶液,将(3)中制得的材料放入戊二醛溶液中浸泡30min,取出用水清洗,烘干得到修饰上复合膜的骨科临时植入体。(4) A glutaraldehyde solution with a mass fraction of 2.5% was prepared with water, the material prepared in (3) was soaked in the glutaraldehyde solution for 30 minutes, taken out, washed with water, and dried to obtain a temporary orthopaedic implant with a modified composite membrane. into the body.
图1是按照实施例1的步骤,修饰上复合膜的骨科临时植入体和原植入体进行对比的效果图,从图1中可以看到,通过实施例1的制备方法,植入体表面均匀修饰上一层膜。Figure 1 is an effect diagram of comparing the orthopaedic temporary implant modified with a composite membrane and the original implant according to the steps of Example 1. As can be seen from Figure 1, by the preparation method of Example 1, the implant is The surface is evenly decorated with a layer of film.
图2(a)是按照实施例1的步骤(1)将多糖进行醛化后与原多糖就行对比的效果图,醛化前,多糖为粉末状,并略微发黄,醛化后,呈白色棉絮状,并用希夫试剂对多糖进行显色反应——具体操作步骤为在试管中加入1mL希夫试剂,向其中投入一定量的醛化前后多糖,放置一段时间后进行观察,由图2(b)可见,未醛化多糖与希夫试剂不发生显色反应,醛化后的多糖,由于醛基与希夫试剂发生反应,溶液变为紫色,证明多糖被成功醛化。Figure 2(a) is an effect diagram of comparing the polysaccharide with the original polysaccharide after hydroformylation according to the step (1) of Example 1. Before hydroformylation, the polysaccharide is powdery and slightly yellow, and after hydroformylation, it is white Cotton flocculent, and the color reaction of polysaccharide is carried out with Schiff's reagent - the specific operation steps are to add 1 mL of Schiff's reagent to the test tube, put a certain amount of polysaccharide before and after hydroformylation into it, and observe it after placing it for a period of time, as shown in Figure 2 ( b) It can be seen that the unformaldehyde polysaccharide does not react with the Schiff reagent. After the hydroformylation of the polysaccharide, due to the reaction between the aldehyde group and the Schiff reagent, the solution turns purple, which proves that the polysaccharide is successfully hydroformylated.
实施例2Example 2
(1)将1g海藻酸钠用1.03g高碘酸钠在25℃下反应24h,然后用去离子水透析3天,冻干,得到所需的醛化度为56%的醛化海藻酸钠;(1) 1 g of sodium alginate was reacted with 1.03 g of sodium periodate at 25°C for 24 hours, then dialyzed with deionized water for 3 days, and freeze-dried to obtain the required hydroformylation sodium alginate with a degree of hydroformylation of 56%. ;
(2)在西林瓶中加入150mg明胶,加入3mL水在60℃加热溶解,得到溶液1,称取20mg抗生素溶于2mLpH=10的碳酸钠溶液,得到溶液2,将溶液2加入溶液1中混合均匀,混合一段时间后加入50mg的醛化度为56%的醛化海藻酸钠,制得成膜液;(2) Add 150 mg of gelatin to the vial, add 3 mL of water and heat at 60°C to dissolve to obtain solution 1, weigh 20 mg of antibiotics and dissolve in 2 mL of sodium carbonate solution with pH=10 to obtain solution 2, add solution 2 to solution 1 and mix Evenly, after mixing for a period of time, add 50 mg of hydroformyl sodium alginate with a degree of hydroformylation of 56% to obtain a film-forming liquid;
(3)在反应器中放入骨科临时植入体,加入成膜液,整个体系在40℃缓慢挥发7h,骨科临时植入体表面均匀包裹上复合膜。(3) Put the orthopaedic temporary implant in the reactor, add the film-forming solution, the whole system is slowly volatilized at 40°C for 7 hours, and the surface of the orthopaedic temporary implant is evenly wrapped with a composite film.
(4)用水配制质量分数为2.5%的戊二醛溶液,将(3)中制得的材料放入戊二醛溶液中浸泡30min,取出用水清洗,烘干得到修饰上复合膜的骨科临时植入体。(4) A glutaraldehyde solution with a mass fraction of 2.5% was prepared with water, the material prepared in (3) was soaked in the glutaraldehyde solution for 30 minutes, taken out, washed with water, and dried to obtain a temporary orthopaedic implant with a modified composite membrane. into the body.
实施例3Example 3
(1)将1g海藻酸钠用1.5g高碘酸钠在25℃下反应24h,然后用去离子水透析3天,冻干,得到所需的醛化度为81.3%的醛化海藻酸钠;(1) 1 g of sodium alginate was reacted with 1.5 g of sodium periodate at 25°C for 24 hours, then dialyzed with deionized water for 3 days, and freeze-dried to obtain the required hydroformylation sodium alginate with a degree of hydroformylation of 81.3%. ;
(2)在西林瓶中加入150mg明胶,加入3mL水在60℃加热溶解,得到溶液1,称取20mg抗生素溶于2mLpH=10的碳酸钠溶液,得到溶液2,将溶液2加入溶液1中混合均匀,混合一段时间后加入50mg的醛化度为81.3%的醛化海藻酸钠,制得成膜液;(2) Add 150 mg of gelatin to the vial, add 3 mL of water and heat at 60°C to dissolve to obtain solution 1, weigh 20 mg of antibiotics and dissolve in 2 mL of sodium carbonate solution with pH=10 to obtain solution 2, add solution 2 to solution 1 and mix Evenly, after mixing for a period of time, add 50 mg of hydroformyl sodium alginate with a degree of hydroformylation of 81.3% to obtain a film-forming liquid;
(3)在反应器中放入骨科临时植入体,加入成膜液,整个体系在40℃缓慢挥发7h,骨科临时植入体表面均匀包裹上复合膜。(3) Put the orthopaedic temporary implant in the reactor, add the film-forming solution, the whole system is slowly volatilized at 40°C for 7 hours, and the surface of the orthopaedic temporary implant is evenly wrapped with a composite film.
(4)用水配制质量分数为2.5%的戊二醛溶液,将(3)中制得的材料放入戊二醛溶液中浸泡30min,取出用水清洗,烘干得到修饰上复合膜的骨科临时植入体。(4) A glutaraldehyde solution with a mass fraction of 2.5% was prepared with water, the material prepared in (3) was soaked in the glutaraldehyde solution for 30 minutes, taken out, washed with water, and dried to obtain a temporary orthopaedic implant with a modified composite membrane. into the body.
实施例4Example 4
(1)将1g透明质酸钠用0.532g高碘酸钠在25℃下反应24h,然后用去离子水透析3天,冻干,得到所需的醛化度为45%的醛化透明质酸钠;(1) 1 g of sodium hyaluronate was reacted with 0.532 g of sodium periodate at 25°C for 24 h, then dialyzed with deionized water for 3 days, and freeze-dried to obtain the desired hydroformylation degree of 45% of hydroformyl hyaluronate sodium;
(2)在西林瓶中加入100mg果胶,加入3mL水在60℃加热溶解,得到溶液1,称取20mg抗生素溶于2mLpH=10的碳酸钠溶液,得到溶液2,将溶液2加入溶液1中混合均匀,混合一段时间后加入50mg的醛化度为45%的醛化透明质酸钠,制得成膜液;(2) Add 100 mg of pectin to the vial, add 3 mL of water and heat at 60°C to dissolve to obtain solution 1, weigh 20 mg of antibiotics and dissolve in 2 mL of sodium carbonate solution with pH=10 to obtain solution 2, add solution 2 to solution 1 Mix evenly, and after mixing for a period of time, add 50 mg of hydroformyl sodium hyaluronate with a degree of hydroformylation of 45% to prepare a film-forming liquid;
(3)在反应器中放入骨科临时植入体,加入成膜液,整个体系在40℃缓慢挥发7h,骨科临时植入体表面均匀包裹上复合膜。(3) Put the orthopaedic temporary implant in the reactor, add the film-forming solution, the whole system is slowly volatilized at 40°C for 7 hours, and the surface of the orthopaedic temporary implant is evenly wrapped with a composite film.
(4)用水配制质量分数为2.5%的戊二醛溶液,将(3)中制得的材料放入戊二醛溶液中浸泡30min,取出用水清洗,烘干得到修饰上复合膜的骨科临时植入体。(4) A glutaraldehyde solution with a mass fraction of 2.5% was prepared with water, the material prepared in (3) was soaked in the glutaraldehyde solution for 30 minutes, taken out, washed with water, and dried to obtain a temporary orthopaedic implant with a modified composite membrane. into the body.
实施例5Example 5
(1)将1g葡聚糖用0.924g高碘酸钠在25℃下反应24h,然后用去离子水透析3天,冻干,得到所需的醛化度为55.3%的醛化透明质酸钠;(1) 1 g of dextran was reacted with 0.924 g of sodium periodate at 25°C for 24 h, then dialyzed with deionized water for 3 days, and freeze-dried to obtain the desired hydroformylation degree of hyaluronic acid of 55.3%. sodium;
(2)在西林瓶中加入150mg黄原胶,加入3mL水在60℃加热溶解,得到溶液1,称取20mg抗生素溶于2mLpH=10的碳酸钠溶液,得到溶液2,将溶液2加入溶液1中混合均匀,混合一段时间后加入50mg的醛化度为55.3%的醛化葡聚糖,制得成膜液;(2) Add 150 mg of xanthan gum to the vial, add 3 mL of water and heat at 60°C to dissolve to obtain solution 1, weigh 20 mg of antibiotics and dissolve in 2 mL of sodium carbonate solution with pH=10 to obtain solution 2, add solution 2 to solution 1 Mix well, and after mixing for a period of time, add 50 mg of hydroformyl dextran with a degree of hydroformylation of 55.3% to prepare a film-forming liquid;
(3)在反应器中放入骨科临时植入体,加入成膜液,整个体系在40℃缓慢挥发7h,骨科临时植入体表面均匀包裹上复合膜。(3) Put the orthopaedic temporary implant in the reactor, add the film-forming solution, the whole system is slowly volatilized at 40°C for 7 hours, and the surface of the orthopaedic temporary implant is evenly wrapped with a composite film.
(4)用水配制质量分数为2.5%的戊二醛溶液,将(3)中制得的材料放入戊二醛溶液中浸泡30min,取出用水清洗,烘干得到修饰上复合膜的骨科临时植入体。(4) A glutaraldehyde solution with a mass fraction of 2.5% was prepared with water, the material prepared in (3) was soaked in the glutaraldehyde solution for 30 minutes, taken out, washed with water, and dried to obtain a temporary orthopaedic implant with a modified composite membrane. into the body.
对比例1Comparative Example 1
(1)将1g海藻酸钠用1.03g高碘酸钠在25℃下反应24h,然后用去离子水透析3天,冻干,得到所需的醛化度为56%的醛化海藻酸钠;(1) 1 g of sodium alginate was reacted with 1.03 g of sodium periodate at 25°C for 24 hours, then dialyzed with deionized water for 3 days, and freeze-dried to obtain the required hydroformylation sodium alginate with a degree of hydroformylation of 56%. ;
(2)在西林瓶中加入100mg明胶,加入3mL水在60℃加热溶解,得到溶液1,称取20mg抗生素溶于2mLpH=10的碳酸钠溶液,得到溶液2,将溶液2加入溶液1中混合均匀,混合一段时间后加入150mg的醛化度为56%的醛化海藻酸钠,制得成膜液;(2) Add 100 mg of gelatin to the vial, add 3 mL of water and heat at 60°C to dissolve to obtain solution 1, weigh 20 mg of antibiotics and dissolve in 2 mL of sodium carbonate solution with pH=10 to obtain solution 2, add solution 2 to solution 1 and mix Evenly, after mixing for a period of time, add 150 mg of hydroformyl sodium alginate with a degree of hydroformylation of 56% to prepare a film-forming liquid;
(3)在反应器中放入骨科临时植入体,加入成膜液,整个体系在40℃缓慢挥发7h,骨科临时植入体表面均匀包裹上复合膜。(3) Put the orthopaedic temporary implant in the reactor, add the film-forming solution, the whole system is slowly volatilized at 40°C for 7 hours, and the surface of the orthopaedic temporary implant is evenly wrapped with a composite film.
(4)用水配制质量分数为2.5%的戊二醛溶液,将(3)中制得的材料放入戊二醛溶液中浸泡30min,取出用水清洗,烘干得到修饰上复合膜的骨科临时植入体。(4) A glutaraldehyde solution with a mass fraction of 2.5% was prepared with water, the material prepared in (3) was soaked in the glutaraldehyde solution for 30 minutes, taken out, washed with water, and dried to obtain a temporary orthopaedic implant with a modified composite membrane. into the body.
对比例2Comparative Example 2
(1)将1g海藻酸钠用1.03g高碘酸钠在25℃下反应24h,然后用去离子水透析3天,冻干,得到所需的醛化度为56%的醛化海藻酸钠;(1) 1 g of sodium alginate was reacted with 1.03 g of sodium periodate at 25°C for 24 hours, then dialyzed with deionized water for 3 days, and freeze-dried to obtain the required hydroformylation sodium alginate with a degree of hydroformylation of 56%. ;
(2)在西林瓶中加入100mg明胶,加入3mL水在60℃加热溶解,得到溶液1,称取20mg抗生素溶于2mLpH=10的碳酸钠溶液,得到溶液2,将溶液2加入溶液1中混合均匀,混合一段时间后加入100mg的醛化度为56%的醛化海藻酸钠,制得成膜液;(2) Add 100 mg of gelatin to the vial, add 3 mL of water and heat at 60°C to dissolve to obtain solution 1, weigh 20 mg of antibiotics and dissolve in 2 mL of sodium carbonate solution with pH=10 to obtain solution 2, add solution 2 to solution 1 and mix Evenly, after mixing for a period of time, add 100 mg of hydroformyl sodium alginate with a degree of hydroformylation of 56% to prepare a film-forming liquid;
(3)在反应器中放入骨科临时植入体,加入成膜液,整个体系在40℃缓慢挥发7h,骨科临时植入体表面均匀包裹上复合膜。(3) Put the orthopaedic temporary implant in the reactor, add the film-forming solution, the whole system is slowly volatilized at 40°C for 7 hours, and the surface of the orthopaedic temporary implant is evenly wrapped with a composite film.
(4)用水配制质量分数为2.5%的戊二醛溶液,将(3)中制得的材料放入戊二醛溶液中浸泡30min,取出用水清洗,烘干得到修饰上复合膜的骨科临时植入体。(4) A glutaraldehyde solution with a mass fraction of 2.5% was prepared with water, the material prepared in (3) was soaked in the glutaraldehyde solution for 30 minutes, taken out, washed with water, and dried to obtain a temporary orthopaedic implant with a modified composite membrane. into the body.
图4(a)为按对比例1的制备方法制备的材料表面成膜情况,(b)为按对比例2的制备方法制备的材料表面成膜情况,从图4可以看出,当补强多糖与醛化多糖配比不合适——即当补强多糖与醛化多糖比例为1:1或醛化多糖配比高于补强多糖时,材料表面成膜不均匀,膜存在破碎翘起现象,在表面粘附效果较差易脱落。Figure 4(a) shows the film formation on the surface of the material prepared by the preparation method of Comparative Example 1, and (b) shows the film formation on the surface of the material prepared by the preparation method of Comparative Example 2. It can be seen from Figure 4 that when the reinforcement is reinforced The ratio of polysaccharide and hydroformyl polysaccharide is inappropriate - that is, when the ratio of reinforcing polysaccharide and hydroformyl polysaccharide is 1:1 or the ratio of hydroformyl polysaccharide is higher than that of reinforcing polysaccharide, the film formation on the surface of the material is uneven, and the film is broken and lifted Phenomenon, the adhesion effect on the surface is poor and easy to fall off.
实施例6抗菌性能测试Example 6 Antibacterial performance test
对实施例2、实施例4和实施例5的产品进行抗菌性能测试,所测得结果如图3所示。抗菌性能测试采用ASTM E2149标准。具体过程为取4μL大肠杆菌于4mLLB培养液中,放于37℃摇床中进行孵育,将大肠杆菌孵育至1*108CFU/mL,取出稀释至1*105CFU/mL,在48孔板中分别放入未修饰植入体,按实施例2、4、5修饰的植入体,每组三个平行样,往每个孔中加入300μL1*105CFU/mL的菌液,将孔板放入37℃的摇床中孵育12h,取出孔板从每个孔中吸取100μL的菌液置于96孔板中进行OD600测定,根据测定值计算获得材料的杀菌率。Antibacterial performance tests were carried out on the products of Example 2, Example 4 and Example 5, and the measured results are shown in Figure 3 . Antibacterial properties were tested using ASTM E2149 standard. The specific process is to take 4 μL of Escherichia coli into 4 mL of LB medium, incubate it in a shaker at 37°C, incubate Escherichia coli to 1*10 8 CFU/mL, take out and dilute to 1*10 5 CFU/mL, put it in 48 wells The unmodified implants were placed in the plates, the implants modified according to Examples 2, 4, and 5, three parallel samples in each group, and 300 μL of 1*10 5 CFU/mL bacterial solution was added to each well. The orifice plate was placed in a shaker at 37°C and incubated for 12h, then the plate was taken out and 100 μL of bacterial liquid was drawn from each well and placed in a 96-well plate for OD600 determination.
从图3中可以看出,三种材料均具有良好的抗菌性,三组材料均达到99%的杀菌效果,可以实现快速高效精准杀菌,而对照组(未修饰的原始植入体)无抗菌效果,其表面细菌大量繁殖。As can be seen from Figure 3, all three materials have good antibacterial properties, and all three groups of materials have achieved 99% sterilization effect, which can achieve fast, efficient and precise sterilization, while the control group (unmodified original implant) has no antibacterial properties. As a result, bacteria multiply on its surface.
最后说明的是,以上优选实施例仅用以说明本发明的技术方案而非限制,尽管通过上述优选实施例已经对本发明进行了详细的描述,但本领域技术人员应当理解,可以在形式上和细节上对其作出各种各样的改变,而不偏离本发明权利要求书所限定的范围。Finally, it should be noted that the above preferred embodiments are only used to illustrate the technical solutions of the present invention and not to limit them. Although the present invention has been described in detail through the above preferred embodiments, those skilled in the art should Various changes may be made in details without departing from the scope of the invention as defined by the claims.
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201911162214.8A CN110772664B (en) | 2019-11-25 | 2019-11-25 | A method for preparing a surface intelligent coating of a natural polysaccharide-based orthopedic temporary implant and its product |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201911162214.8A CN110772664B (en) | 2019-11-25 | 2019-11-25 | A method for preparing a surface intelligent coating of a natural polysaccharide-based orthopedic temporary implant and its product |
Publications (2)
Publication Number | Publication Date |
---|---|
CN110772664A true CN110772664A (en) | 2020-02-11 |
CN110772664B CN110772664B (en) | 2023-08-15 |
Family
ID=69392341
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201911162214.8A Active CN110772664B (en) | 2019-11-25 | 2019-11-25 | A method for preparing a surface intelligent coating of a natural polysaccharide-based orthopedic temporary implant and its product |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN110772664B (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113730596A (en) * | 2021-09-15 | 2021-12-03 | 北京化工大学 | Microenvironment adaptive nano-drug delivery system for severe lower respiratory tract infection and preparation method thereof |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1857236A (en) * | 2006-03-08 | 2006-11-08 | 曾敬 | Compound medicine release controlling film of chitosan, sodium alginate and gelatin and its preparing process |
CN102604141A (en) * | 2012-02-29 | 2012-07-25 | 上海工程技术大学 | Method for preparing antibacterial film of quaternarized chitosan iodine complex |
WO2014122631A1 (en) * | 2013-02-11 | 2014-08-14 | Lacerta Technologies Inc. | Tissue substitute material with biologically active coating |
CN106758217A (en) * | 2016-12-31 | 2017-05-31 | 武汉工程大学 | A kind of crosslinking preparation method of gelatin/chitosan composite nano-fiber membrane |
CN106822911A (en) * | 2016-10-20 | 2017-06-13 | 华东师范大学 | A kind of antibiosis hydrogel of controlled release and its preparation method and application |
CN110314242A (en) * | 2018-11-09 | 2019-10-11 | 上海长征医院 | A kind of preparation method and its usage of the antibiotic composite hydrogel of controlled release |
-
2019
- 2019-11-25 CN CN201911162214.8A patent/CN110772664B/en active Active
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1857236A (en) * | 2006-03-08 | 2006-11-08 | 曾敬 | Compound medicine release controlling film of chitosan, sodium alginate and gelatin and its preparing process |
CN102604141A (en) * | 2012-02-29 | 2012-07-25 | 上海工程技术大学 | Method for preparing antibacterial film of quaternarized chitosan iodine complex |
WO2014122631A1 (en) * | 2013-02-11 | 2014-08-14 | Lacerta Technologies Inc. | Tissue substitute material with biologically active coating |
CN106822911A (en) * | 2016-10-20 | 2017-06-13 | 华东师范大学 | A kind of antibiosis hydrogel of controlled release and its preparation method and application |
CN106758217A (en) * | 2016-12-31 | 2017-05-31 | 武汉工程大学 | A kind of crosslinking preparation method of gelatin/chitosan composite nano-fiber membrane |
CN110314242A (en) * | 2018-11-09 | 2019-10-11 | 上海长征医院 | A kind of preparation method and its usage of the antibiotic composite hydrogel of controlled release |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113730596A (en) * | 2021-09-15 | 2021-12-03 | 北京化工大学 | Microenvironment adaptive nano-drug delivery system for severe lower respiratory tract infection and preparation method thereof |
CN113730596B (en) * | 2021-09-15 | 2024-03-15 | 北京化工大学 | Micro-environment self-adaptive nano-drug delivery system for severe lower respiratory tract infection and preparation method thereof |
Also Published As
Publication number | Publication date |
---|---|
CN110772664B (en) | 2023-08-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Hu et al. | Rational design and latest advances of polysaccharide-based hydrogels for wound healing | |
Zhou et al. | Konjac glucomannan: A review of structure, physicochemical properties, and wound dressing applications | |
CN113577376B (en) | Double-heavy-load drug polysaccharide-based self-healing hydrogel and preparation method thereof | |
Wang et al. | Polyelectrolyte hydrogels for tissue engineering and regenerative medicine | |
CN106975101B (en) | Nano-silver composite collagen medical dressing and preparation method thereof | |
Pirsa et al. | Hydrogels and biohydrogels: investigation of origin of production, production methods, and application | |
CN110665051B (en) | Preparation method of hemostatic and antibacterial frozen gel stent | |
CN107778497A (en) | A kind of compound covalently hydrogel and its preparation method and application discharged on demand | |
CN108066805A (en) | A kind of bionical bacteriostatic film of epsilon-polylysine and its preparation and application | |
CN105597146A (en) | Multifunctional temperature-sensitive gel composite dressing for wound healing and preparation and usage thereof | |
CN107899077B (en) | A kind of composite antibacterial coating with enhanced stability and its preparation method and application | |
Radha et al. | Chitosan‐based films in drug delivery applications | |
CN114452436B (en) | Collagen-based injectable self-repairing hydrogel and preparation method thereof | |
CN105920652A (en) | Antibacterial gel in covalent grafting with antibacterial polypeptide and preparation method of antibacterial gel | |
CN105641735B (en) | A kind of preparation method of antibiotic property polysaccharide hemostatic cotton base gauze | |
CN106474523A (en) | Preparation method based on the polyelectrolyte sponge wound dressing of carboxymethyl chitosan | |
CN115536919B (en) | A modified chitosan adhesive hydrogel and its preparation method and application | |
Shekhar et al. | Sustainable polysaccharide hydrogels based on dynamic schiff base linkages as versatile building blocks for fabricating advanced functional materials | |
CN113577362B (en) | A kind of nano-zinc oxide/collagen-based antibacterial dressing and preparation method thereof | |
CN110804192A (en) | A kind of cellulose antibacterial hydrogel and preparation method thereof | |
Yang et al. | Self-healing guar gum-based nanocomposite hydrogel promotes infected wound healing through photothermal antibacterial therapy | |
CN116392628A (en) | An injectable in-situ cross-linked antibacterial conductive hydrogel and its preparation method and application | |
Wang et al. | Recent progress of antibacterial hydrogel materials for biomedical applications | |
Rad et al. | Application of thermo-responsive polymers as smart biomaterials in wound dressing | |
CN110772664B (en) | A method for preparing a surface intelligent coating of a natural polysaccharide-based orthopedic temporary implant and its product |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |